AVR 1.21% $23.48 anteris technologies ltd

IMO it would be unlikely that any of the Tiblisi cohort would be...

  1. 2,117 Posts.
    lightbulb Created with Sketch. 189
    IMO it would be unlikely that any of the Tiblisi cohort would be part of the FDA application.
    I am not sure that Tiblisi would be considered gold standard.
    They would be included as secondary supporting documentation only....compelling and integral to the proof of concept confirmation, yes, but still secondary.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$23.48
Change
0.280(1.21%)
Mkt cap ! $424.8M
Open High Low Value Volume
$23.50 $23.55 $23.15 $347.1K 14.83K

Buyers (Bids)

No. Vol. Price($)
1 500 $23.00
 

Sellers (Offers)

Price($) Vol. No.
$23.48 954 1
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
$23.43
  Change
0.280 ( 1.87 %)
Open High Low Volume
$23.47 $23.47 $23.25 161
Last updated 15.35pm 28/03/2024 ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.